FDA News Release
For Immediate Release: October 05, 2020
The U.S. Fda (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:
- FDA granted a brand-new research contract to the Stanford University School of Medicine to perform an in-depth analysis of tissue samples to learn more about how SARS-CoV-2– the infection that causes COVID-19– impacts various systems in the body, and identify immune correlates. This regulatory science job might potentially assist notify advancement and assessment of medical countermeasures for COVID-19.
- Testing updates:
- As of today, 270 tests are licensed by FDA under EUAs; these consist of 213 molecular tests, 52 antibody tests, and 5 antigen tests.
The FDA, a company within the U.S. Department of Health and Human Solutions, secures the general public health by guaranteeing the security, efficiency, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The firm likewise is responsible for the security and security of our country’s food supply, cosmetics, dietary supplements, items that release electronic radiation, and for controling tobacco products.
Media: Courtney Rhodes 888-INFO-FDA Customer: 888-INFO-FDA